statistiche ricercatore

Continente	#
NA - Nord America	1.371
AS - Asia	509
EU - Europa	379
SA - Sud America	61
AF - Africa	4
OC - Oceania	4
Continente sconosciuto - Info sul continente non disponibili	3
Totale	2.331

Nazione	#
US - Stati Uniti d'America	1.352
SG - Singapore	231
CN - Cina	108
GB - Regno Unito	106
IT - Italia	80
HK - Hong Kong	72
SE - Svezia	52
BR - Brasile	45
VN - Vietnam	43
DE - Germania	42
RU - Federazione Russa	25
FI - Finlandia	22
ID - Indonesia	19
CA - Canada	13
FR - Francia	13
BG - Bulgaria	11
UA - Ucraina	11
TR - Turchia	8
KR - Corea	6
AR - Argentina	5
JP - Giappone	5
MX - Messico	5
NL - Olanda	5
AU - Australia	4
BD - Bangladesh	3
CO - Colombia	3
GR - Grecia	3
UZ - Uzbekistan	3
AZ - Azerbaigian	2
BO - Bolivia	2
CZ - Repubblica Ceca	2
IN - India	2
PE - Perù	2
VE - Venezuela	2
A2 - ???statistics.table.value.countryCode.A2???	1
AT - Austria	1
BE - Belgio	1
CL - Cile	1
DO - Repubblica Dominicana	1
EC - Ecuador	1
ES - Italia	1
ET - Etiopia	1
EU - Europa	1
GH - Ghana	1
IE - Irlanda	1
IL - Israele	1
IR - Iran	1
JO - Giordania	1
KW - Kuwait	1
KZ - Kazakistan	1
LK - Sri Lanka	1
LT - Lituania	1
ML - Mali	1
PK - Pakistan	1
PL - Polonia	1
SI - Slovenia	1
XK - ???statistics.table.value.countryCode.XK???	1
ZA - Sudafrica	1
Totale	2.331

Nome	#
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study	336
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease	283
Genome-wide definition of promoter and enhancer usage during neural induction of human embryonic stem cells	256
Correction of Laminin-5 Deficiency in Human Epidermal Stem Cells by Transcriptionally Targeted Lentiviral Vectors	251
Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID	222
Interactions between Retroviruses and the Host Cell Genome	194
An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype	179
Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study	167
Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors	159
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia	158
Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency	153
Totale	2.358

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	275	0	0	0	0	0	47	32	56	23	46	21	50
2021/2022	246	31	17	9	14	5	19	8	15	26	37	35	30
2022/2023	239	36	37	11	19	31	30	5	19	24	2	9	16
2023/2024	154	6	5	15	11	31	4	9	38	4	1	4	26
2024/2025	477	8	1	2	48	102	65	22	30	70	22	41	66
2025/2026	359	48	28	42	64	161	16	0	0	0	0	0	0
Totale													2.358